Lanzoprax Kid 30 Tablet contains Lansoprazole 30 mg, a proton pump inhibitor (PPI) used primarily to reduce gastric acid secretion in pediatric patients. Lansoprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step in acid production. This medication is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, gastric and duodenal ulcers, and Zollinger-Ellison syndrome in children. Lanzoprax Kid 30 Tablet is effective in promoting healing of acid-related mucosal damage and alleviating associated symptoms such as heartburn, regurgitation, and epigastric pain. The drug is generally well tolerated, with common adverse effects including headache, abdominal pain, diarrhea, and nausea. It is important to administer Lanzoprax Kid 30 Tablet as prescribed, typically before meals to maximize acid suppression. Caution is advised in patients with known hypersensitivity to Lansoprazole or other PPIs. Long-term use should be monitored due to potential risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Consultation with a healthcare professional is essential for appropriate diagnosis and treatment monitoring.